查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2009011

兒童疫苗市場報告：按類型、技術、應用和地區分類（2026-2034年）

Pediatric Vaccines Market Report by Type (Multivalent, Monovalent), Technology (Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid, and Others), Application (Infectious Disease, Cancer, Allergy, and Others), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

2025年全球兒童疫苗市場規模達424億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到751億美元，2026年至2034年的複合年成長率為6.35%。市場成長的主要促進因素包括免疫接種計畫的擴大、對聯合疫苗的日益重視，以及製藥公司與醫療機構之間為加速疫苗研發和分發而不斷加強的合作。

兒童疫苗是一種刺激免疫系統辨識並對抗特定病原體（例如細菌和病毒）的藥物製劑。它們含有減毒或去活化的病原體或其成分，使免疫系統能夠建立針對特定疾病的防禦機制。兒童疫苗可預防麻疹、脊髓灰質炎、百日咳、肝炎和流感。兒童疫苗在核准使用前均需經過嚴格的檢測和評估，以確保其安全性。它們有助於預防可能導致兒童嚴重併發症甚至死亡的疾病傳播。

目前，兒童中各種感染疾病和潛在危及生命的疾病（例如脊髓灰質炎、結核病和瘧疾）的發病率不斷上升，正在推動市場成長。此外，全球各國政府不斷擴大兒童免疫接種計劃，以預防可預防疾病，也促進了市場成長。疫苗儲存和分發技術的進步，改善了醫療基礎設施低度開發地區的供應鏈，為市場創造了有利前景。此外，製藥公司與醫療機構之間日益增多的合作，加速了疫苗的研發和分發，也為市場成長提供了支持。最後，全球範圍內為改善醫療服務而不斷增加的診所和醫院建設，也推動了市場成長。

兒童疫苗市場的發展趨勢與促進因素：

擴大免疫接種計劃

免疫接種計劃的擴展顯著推動了兒童疫苗市場的發展。這些由政府和非政府組織支持的免疫接種工作在保護兒童健康和福祉方面發揮著至關重要的作用。隨著越來越多的兒童接種針對各種疾病的必要疫苗，兒童疫苗的需求也隨之增加。此外，以疾病預防為重點的免疫接種計劃正在降低兒童特定疾病的發生率。因此，醫療系統和家庭的負擔得以減輕，兒童及其看護者的整體生活品質也得到提升。此外，家長和醫護人員對免疫接種重要性的認知不斷提高，也促使疫苗接種率不斷攀升。

人們越來越關注聯合疫苗

人們對聯合疫苗日益成長的興趣推動了兒童疫苗市場的強勁表現。聯合疫苗透過在單一製劑中提供對多種疾病的保護，實現了免疫接種的策略性方法。這種方法簡化了醫護人員、家長和兒童的免疫接種流程，從而提高了免疫接種的依從性和接種率。此外，聯合疫苗也解決了疫苗接種猶豫和劑量不足等挑戰。兒童只需注射一次即可獲得多種疾病的保護，顯著減輕了疫苗接種帶來的負擔。這鼓勵家長遵循建議的疫苗接種計劃，從而有助於提高全程免疫接種率。

新疫苗研發的擴展

新疫苗研發的加速發展在推動兒童疫苗市場的強勁成長中發揮著至關重要的作用。針對兒童健康需求而研發的新疫苗的出現，有助於加強疾病預防、改善公共衛生狀況並擴大市場機會。此外，新疫苗的研發也反映了疫苗技術和研發領域的進步。基因組學和生物資訊學等前沿調查方法使科學家能夠更快、更準確地識別潛在的候選疫苗。這種加速的發現速度正在推動高效疫苗的研發，這些疫苗能夠適應不斷變化的流行病學情況。此外，新疫苗研發活動的增加也促進了公共衛生機構、研究機構和疫苗生產商之間的合作。這些夥伴關係有助於新疫苗的及時推出，並確保有效地分發給兒童群體。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球兒童疫苗市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依類型

  • 多價
  • 一價

第7章 市場區隔：依技術分類

  • 共軛物
  • 減毒活病毒疫苗
  • 失活
  • 次單元
  • 類毒素
  • 其他

第8章 市場區隔：依應用領域分類

  • 感染疾病
  • 癌症
  • 過敏
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Bio-Med（P）Limited
    • Daiichi Sankyo Company Limited
    • GSK plc
    • Indian Immunologicals Limited
    • Merck & Co. Inc.
    • Panacea Biotec
    • Pfizer Inc.
    • Sanofi
Product Code: SR112026A6230

The global pediatric vaccines market size reached USD 42.4 Billion in 2025 . Looking forward, IMARC Group expects the market to reach USD 75.1 Billion by 2034 , exhibiting a growth rate (CAGR) of 6.35% during 2026-2034 . The growing conduction of vaccination programs, increasing focus on combination vaccines, and rising partnerships between pharmaceutical companies and healthcare organizations for fast-tracking the development and distribution of vaccines are some of the major factors propelling the market.

Pediatric vaccines are medical preparations that stimulate the immune system to recognize and fight specific infectious agents, such as bacteria or viruses. They comprise weakened or inactivated forms of the pathogens, or components of the pathogens, which prompt the immune system to develop a defense mechanism against the targeted disease. They provide protection from measles, polio, pertussis (whooping cough), hepatitis, and influenza. They undergo rigorous testing and evaluation to ensure their safety before being approved for use. They prevent the spread of diseases that can cause severe complications or death in children.

At present, the increasing occurrence of various infectious and potentially life-threatening diseases, such as polio, tuberculosis (TB), and malaria among children, is impelling the growth of the market. Besides this, rising government initiatives around the world aimed at immunizing children against preventable diseases are contributing to the growth of the market. In addition, the growing technological advancements in vaccine storage and distribution methods for improving the supply chain in regions where medical infrastructure may be less developed are offering a favorable market outlook. Apart from this, increasing partnerships between pharmaceutical companies and healthcare organizations for fast-tracking the development and distribution of vaccines are supporting the growth of the market. Additionally, the rising construction of clinics and hospitals around the world to improve healthcare services is bolstering the growth of the market.

PEDIATRIC VACCINES MARKET TRENDS/DRIVERS:

Growing conduction of vaccination programs

The increasing implementation of vaccination programs is notably bolstering the pediatric vaccines market. These vaccination initiatives, supported by governmental and non-governmental organizations, play a pivotal role in safeguarding the health and well-being of children. As more children receive essential immunizations against various diseases, the demand for pediatric vaccines experiences a proportional rise. Besides this, vaccination programs, with their focus on disease prevention, are decreasing the incidence of targeted illnesses among children. This subsequently translates into a reduced burden on healthcare systems and families, thereby enhancing the overall quality of life for children and their caregivers. Furthermore, the growing awareness among parents and healthcare providers about the importance of immunizations is rising the vaccine uptake rates.

Increasing focus on combination vaccines

The heightened emphasis on combination vaccines is contributing to the positive evolution of the pediatric vaccines market. Combination vaccines offer a strategic approach to immunization by providing protection against multiple diseases in a single formulation. This approach simplifies the vaccination process for healthcare providers, caregivers, and children alike, resulting in improved compliance and vaccine coverage rates. Moreover, combination vaccines address the challenges of vaccine hesitancy and the possibility of missed doses. As children receive protection against multiple diseases with one injection, the perceived burden of vaccinations is significantly reduced. This encourages parents to adhere to recommended vaccination schedules and contributes to achieving higher rates of full immunization coverage.

Rising development of novel vaccines

The increasing development of novel vaccines is playing a pivotal role in driving positive growth within the pediatric vaccines market. The emergence of new vaccines tailored specifically for the health needs of children contributes to enhanced disease prevention, improved public health outcomes, and expanded market opportunities. The development of novel vaccines also reflects advancements in vaccine technology and research. Cutting-edge research methodologies, such as genomics and bioinformatics, enable scientists to identify potential vaccine candidates more rapidly and accurately. This accelerated pace of discovery is creating vaccines that are efficacious and align with the evolving epidemiological landscape. Furthermore, the rising development of novel vaccines is stimulating collaboration between public health organizations, research institutions, and vaccine manufacturers. These partnerships facilitate the timely introduction of new vaccines and ensure their efficient distribution to the pediatric population.

PEDIATRIC VACCINES INDUSTRY SEGMENTATION:

Breakup by Type:

  • Multivalent
  • Monovalent

Multivalent dominates the market

Multivalent pediatric vaccines refer to immunization formulations that provide protection against multiple diseases through a single vaccine injection. These vaccines are designed to target two or more different disease-causing agents, such as viruses or bacteria, in a single formulation. Multivalent pediatric vaccines streamline the vaccination process by offering protection against multiple diseases with a single injection. This eliminates the need for multiple shots, reducing discomfort for children and simplifying the vaccination schedule for healthcare providers and caregivers. Multivalent pediatric vaccines optimize healthcare resources by combining multiple vaccines into a single formulation. This can result in cost savings for healthcare systems and reduce the logistical challenges associated with administering separate vaccines.

Breakup by Technology:

  • Conjugate
  • Live Attenuated
  • Inactivated
  • Subunit
  • Toxoid
  • Others

Conjugate holds the largest share in the market

Conjugate vaccines are a type of immunization that enhances the immune response against certain bacteria that have a protective polysaccharide outer coating. These vaccines work by linking or conjugating the bacterial polysaccharides to a carrier protein, creating a complex that stimulates a stronger and more effective immune response, especially in young children whose immune systems might not respond well to polysaccharides alone. Conjugate vaccines not only protect vaccinated individuals but can also reduce the carriage of bacteria in the population. This indirectly limits the spread of bacteria among both vaccinated and unvaccinated individuals. Conjugate vaccines contribute to herd immunity, which is essential for the prevention of the spreading of various infectious diseases among unvaccinated individuals.

Breakup by Application:

  • Infectious Disease
  • Cancer
  • Allergy
  • Others

Pediatric vaccines play a crucial role in preventing infectious diseases among children. By providing immunity against harmful pathogens, vaccines contribute to the health and well-being of children and infants. These vaccines are carefully developed based on scientific examination and clinical trials to ensure their safety and effectiveness.

Pediatric vaccines for cancer aim to prevent certain types of cancers that primarily affect children. They target certain infections, such as human papillomavirus (HPV) and hepatitis B virus (HBV) and are known to increase the risk of developing cancer. Besides this, administering vaccines during childhood allows for early prevention of cancer-related infections. This early intervention aligns with a proactive health approach, reducing the risk of cancer development later in life.

Pediatric vaccines play a crucial role in preventing a range of allergies among children. By bolstering the response of the immune system, vaccines help mitigate the risk of developing allergies to common allergens like pollen, dust, and pet dander.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest pediatric vaccines market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share since the region due to the rising investment in research operations for the development of various novel vaccines for the prevention of infectious and chronic diseases. Besides this, the increasing awareness among parents and caregivers about the importance of immunization is propelling the growth of the market. Apart from this, rising improvements in the healthcare infrastructure to provide quality treatment and other healthcare facilities to individuals are supporting the growth of the market.

Asia Pacific is estimated to expand further in this domain due to the increasing occurrence of infectious diseases caused by various novel viruses. Besides this, rising initiatives taken by governing agencies and regulatory bodies to promote the significance of vaccination in children are bolstering the growth of the market.

COMPETITIVE LANDSCAPE:

Key market players are diligently focused on enhancing their business strategies by consistently investing in research operations to formulate innovative vaccines that cater to evolving healthcare needs. They are fostering collaborations with research institutions and regulatory bodies to ensure the safety and efficacy of their products. Leading companies are strengthening their supply chain management and distribution networks to ensure timely availability of vaccines. Furthermore, top industry players are actively engaging in educational initiatives to increase awareness about the importance of vaccination, fostering trust and credibility within the community. This concerted effort to innovate, collaborate, and educate showcases their commitment to advancing the field of pediatric vaccines and contributing to public health on a global scale.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Bio-Med (P) Limited
  • Daiichi Sankyo Company Limited
  • GSK plc
  • Indian Immunologicals Limited
  • Merck & Co. Inc.
  • Panacea Biotec
  • Pfizer Inc.
  • Sanofi

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global pediatric vaccines market in 2025?

2. What is the expected growth rate of the global pediatric vaccines market during 2026-2034?

3. What are the key factors driving the global pediatric vaccines market?

4. What has been the impact of COVID-19 on the global pediatric vaccines market?

5. What is the breakup of the global pediatric vaccines market based on the type?

6. What is the breakup of the global pediatric vaccines market based on the technology?

7. What are the key regions in the global pediatric vaccines market?

8. Who are the key players/companies in the global pediatric vaccines market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pediatric Vaccines Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Multivalent
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Monovalent
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Conjugate
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Live Attenuated
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Inactivated
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Subunit
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Toxoid
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Infectious Disease
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cancer
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Allergy
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Bio-Med (P) Limited
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Daiichi Sankyo Company Limited
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 GSK plc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Indian Immunologicals Limited
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Merck & Co. Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Panacea Biotec
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Pfizer Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Sanofi
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Pediatric Vaccines Market: Major Drivers and Challenges
  • Figure 2: Global: Pediatric Vaccines Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Pediatric Vaccines Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Pediatric Vaccines Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Pediatric Vaccines Market: Breakup by Technology (in %), 2025
  • Figure 6: Global: Pediatric Vaccines Market: Breakup by Application (in %), 2025
  • Figure 7: Global: Pediatric Vaccines Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Pediatric Vaccines (Multivalent) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Pediatric Vaccines (Multivalent) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Pediatric Vaccines (Monovalent) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Pediatric Vaccines (Monovalent) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Pediatric Vaccines (Conjugate) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Pediatric Vaccines (Conjugate) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Pediatric Vaccines (Live Attenuated) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Pediatric Vaccines (Live Attenuated) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Pediatric Vaccines (Inactivated) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Pediatric Vaccines (Inactivated) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Pediatric Vaccines (Subunit) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Pediatric Vaccines (Subunit) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Pediatric Vaccines (Toxoid) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Pediatric Vaccines (Toxoid) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Pediatric Vaccines (Other Technologies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Pediatric Vaccines (Other Technologies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Pediatric Vaccines (Infectious Disease) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Pediatric Vaccines (Infectious Disease) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Pediatric Vaccines (Cancer) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Pediatric Vaccines (Cancer) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Pediatric Vaccines (Allergy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Pediatric Vaccines (Allergy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Pediatric Vaccines (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Pediatric Vaccines (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: North America: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: North America: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: United States: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: United States: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Canada: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Canada: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Asia-Pacific: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Asia-Pacific: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: China: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: China: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Japan: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Japan: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: India: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: India: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: South Korea: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: South Korea: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Australia: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Australia: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Indonesia: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Indonesia: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Others: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Others: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Europe: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Europe: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Germany: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Germany: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: France: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: France: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: United Kingdom: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: United Kingdom: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Italy: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Italy: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Spain: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Spain: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Russia: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Russia: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Others: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Others: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Latin America: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Latin America: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Brazil: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Brazil: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Mexico: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Mexico: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Others: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Others: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Middle East and Africa: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Middle East and Africa: Pediatric Vaccines Market: Breakup by Country (in %), 2025
  • Figure 80: Middle East and Africa: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Global: Pediatric Vaccines Industry: SWOT Analysis
  • Figure 82: Global: Pediatric Vaccines Industry: Value Chain Analysis
  • Figure 83: Global: Pediatric Vaccines Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pediatric Vaccines Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Pediatric Vaccines Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Pediatric Vaccines Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 4: Global: Pediatric Vaccines Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 5: Global: Pediatric Vaccines Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Pediatric Vaccines Market: Competitive Structure
  • Table 7: Global: Pediatric Vaccines Market: Key Players